Fed­er­al judge dis­miss­es kick­back claims in No­var­tis whistle­blow­er case — again

When a fed­er­al judge dis­missed a whistle­blow­er case against No­var­tis back in 2020, the court gave plain­tiffs one last chance to prove the phar­ma gi­ant bribed physi­cians to pre­scribe its mul­ti­ple scle­ro­sis drug Gilenya. On Tues­day, those ef­forts came up short.

US Dis­trict Judge Kim­ba Wood of South­ern New York ruled once again that for­mer No­var­tis sales rep Steven Cam­burn’s com­plaint lacked suf­fi­cient de­tail to sup­port claims that No­var­tis de­ployed a kick­back scheme to boost Gilenya pre­scrip­tions.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.